Article
Earlier Application of Methylene Blue in Vasoplegic, Adrenergic Vasopressor-Resistant Patients is Associated with Better Clinical Outcomes. A Retrospective Analysis of 464 Patients
2025-12-22
Abstract excerpt
<title>Abstract</title> <p> Background. Severe shock, characterized by profound and refractory hypotension, hails a dismal prognosis for patients in intensive care units. Management typically involves fluid resuscitation and vasopressor support. Vasoplegic patients, refractory to adrenergic catecholamines face an increased risk for in-hospital mortality. However, the optimal timing for Methylene Blue (MB) in th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8ffba1b9-089c-5283-a0b0-1cdb45b6e933
- DOI
- 10.21203/rs.3.rs-8181160/v1
